Cargando…

Impact of Long-Term Dexamethasone Therapy on the Metabolic Profile of Patients With 21-Hydroxylase Deficiency

CONTEXT: No consensus has been reached regarding the glucocorticoid (GC) to use for congenital adrenal hyperplasia (CAH) during adulthood. Dexamethasone (DEX), because of its longer half-life, could improve compliance; however, no data are available regarding the long-term effects of DEX therapy. OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seraphim, Carlos E, Frassei, Juliana S, Pessoa, Bruna S, Scalco, Renata C, Miranda, Mirela C, Madureira, Guiomar, Mendonca, Berenice B, Bachega, Tania A S S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676077/ https://www.ncbi.nlm.nih.gov/pubmed/31384718 http://dx.doi.org/10.1210/js.2019-00123

Ejemplares similares

PSAT072 Clinical Features of Patients with 21-Hydroxylase Deficiency and Testicular Adrenal Rest Tumors
por: Bachega, Tânia A S S, et al.
Publicado: (2022)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Gomes, Larissa G., et al.
Publicado: (2013)

Effects of Pre and Post-Natal Androgen Exposure on Psychosexual Aspects and Gender Change in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
por: Batista, Rafael Loch, et al.
Publicado: (2021)

SUN-071 Prenatal and Post-Natal Influence of Androgens in the Psychosexual Development in Individuals with 21-hydroxylase Congenital Adrenal Hyperplasia
por: Batista, Rafael Loch, et al.
Publicado: (2020)

The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene
por: Moura-Massari, Vivian Oliveira, et al.
Publicado: (2016)

Impact of Glucocorticoid Receptor Gene Polymorphisms on the Metabolic Profile of Adult Patients with the Classical Form of 21-Hydroxylase Deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2012)

SUN-361 Reproductive Outcomes in Females with Virilizing Forms of Congenital Adrenal Hyperplasia
por: Falcao, Camila, et al.
Publicado: (2019)

Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2011)

RF21 | PSAT93 Improvement of Final Height in Congenital Adrenal Hyperplasia Patients Treated With Recombinant Growth Hormone
por: Costa, Fernanda C, et al.
Publicado: (2022)

Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence
por: Miranda, Mirela Costa De, et al.
Publicado: (2019)

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
por: Righi, Beatrice, et al.
Publicado: (2023)

Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
por: Nowotny, Hanna, et al.
Publicado: (2022)

Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
por: Moreira, Ricardo P. P., et al.
Publicado: (2014)

Surgical Treatment after Failed Primary Correction of Urogenital Sinus in Female Patients with Virilizing Congenital Adrenal Hyperplasia: Are Good Results Possible?
por: Sircili, Maria Helena Palma, et al.
Publicado: (2016)

The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts
por: de Miranda, Mirela Costa, et al.
Publicado: (2021)

POR polymorphisms are associated with 21 hydroxylase deficiency
por: Pecori Giraldi, F., et al.
Publicado: (2021)

21-Hydroxylase Deficiency: Newborn Screening in Iran?
por: Mahdieh, Nejat, et al.
Publicado: (2012)

Neonatal mass screening for 21-hydroxylase deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2016)

SUN-172 A False Positive Result in Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in a Girl with Beckwith Wiedemann Syndrome
por: Braga, Barbara Leitao, et al.
Publicado: (2020)

THU210 A Single-center Retrospective Study Of Brazilian Subjects With Differences In Sex Development (DSD) From Infancy To Adulthood
por: Batista, Rafael Loch, et al.
Publicado: (2023)

MON-156 Efficacy and Safety of Prenatal Dexamethasone Treatment in Offspring at Risk for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Xu, Lizhen, et al.
Publicado: (2020)

Two Adults with Adrenal Myelolipoma and 21-Hydroxylase Deficiency
por: Nermoen, Ingrid, et al.
Publicado: (2009)

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
por: Ventura, Annamaria, et al.
Publicado: (2013)

Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase Deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2008)

Monitoring treatment in pediatric patients with 21-hydroxylase deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2023)

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency
por: Tang, Peng, et al.
Publicado: (2023)

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)

Compliance Issues in Managing 21 Hydroxylase Deficiency and their Short/Long-Term Consequences
por: Lin, Jack, et al.
Publicado: (2021)

Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010)

Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
por: Ishii, Tomohiro, et al.
Publicado: (2015)

Health problems of adolescent and adult patients with 21-hydroxylase deficiency
por: Tajima, Toshihiro
Publicado: (2018)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population
por: Dumic, Katja K., et al.
Publicado: (2023)

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021)

Effect of Acute and Chronic Oral Zinc Administration in Hyperprolactinemic Patients
por: Madureira, Guiomar, et al.
Publicado: (1999)

Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Johannsen, T. H., et al.
Publicado: (2010)

Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2021)

Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia
por: Kolahdouz, Mahsa, et al.
Publicado: (2015)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Huge ovarian cyst in a neonate with classical 21-hydroxylase deficiency
por: Abdelmeguid, Yasmine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubn6b6mp59go8vpaod286q8t7p